Helen Takanabe

Helen Takanabe is an accomplished professional in regulatory affairs with extensive experience in the biopharmaceutical industry. Currently serving as Senior Director of Global Regulatory Affairs, CMC at BioMarin Pharmaceutical Inc. since February 2022, Helen previously held various roles at Amgen from May 2006 to January 2022, including Senior Manager and Manager of Regulatory Affairs, as well as Specialist in International Quality Asia. Earlier career experience includes positions as QC Analyst at Cancervax Corporation and Analytical Chemist at Alpha Therapeutic Corp. Helen holds a Bachelor of Science in Biochemistry from UCLA and a Master of Science in Regulatory Science from The Johns Hopkins University.